Phase I-II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma. [electronic resource]
Producer: 19981116Description: 245-51 p. digitalISSN:- 0268-3369
- Adult
- Aged
- Antineoplastic Agents, Alkylating -- administration & dosage
- Combined Modality Therapy
- Drug Administration Schedule
- Drug Tolerance
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- drug therapy
- Transplantation, Autologous
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.